CT scan of the chest revealed ground glass changes while blood tests indicated elevated inflammatory markers and a negative vasculitis screen. This included negative ANCA and anti-GBM antibodies.

Treatment results in remission for about 85% of patients with antineutrophil cytoplasmic antibody (ANCA)-associated small-vessel vasculitis; however, 11–57% of these suffer relapse, which can ...

This study by the French Vasculitis Study Group 1 is not the first setback for methotrexate in the treatment of ANCA-associated vasculitis. A randomized, controlled trial of induction therapy in ...

High resolution CT thorax revealed interstitial lung infiltrates. Nerve conduction study confirmed sensory polyneuropathy with bilateral mononeuritis multiplex of median nerve. Ophthalmological ...

A 65-year-old man with a history of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), congestive heart failure, and peripheral arterial disease presented with fatigue and diffuse ...

Objective: To determine if ECD occurs in a wider spectrum of primary SNV, if it is restricted to the major arteries, and whether vasculitis subgroup, ANCA status, or renal involvement influenced the ...

Objectives To determine the value of PET-CT in the assessment of disease activity in large vessel vasculitis (LVV). Methods 215 PET/CT scans were performed in 78 pts with LVV (giant cell arteritis, ...

Introduction Both rituximab (RTX) and cyclophosphamide (CYC) are effectively used in combination with steroids as remission induction therapy for patients with antineutrophil cytoplasmic antibody ...